Peripal AG signs agreement with Mologic Ltd.

Updated: Oct 26, 2020

Peripal AG signs agreement with Mologic Ltd. to distribute PERiPLEX POC Diagnostic for Peritoneal Dialysis in key European countries Peripal AG is developing support devices, that enable more patients worldwide to stay home and ensure a safe therapy.

Together with Mologic Ltd, a developer of powerful, personalised diagnostics we have signed an agreement to distribute PERiPLEX®, a rapid point-of-care (POC) test for the detection of infection in patients on peritoneal dialysis (PD).

Peripal will supply PERiPLEX as part of a highly complementary product portfolio in the key European markets Germany, Italy, The Netherlands, Austria and Switzerland.

PERiPLEX detects two critical biomarkers of infection in PD waste fluid using a lateral flow immunoassay system and provides a visual result within 5 minutes.

Read more below

20180531_Distributor agreement_Mologic_E
Download • 71KB

May 31, 2018

#healthcare #dialysis #homecare #covid #patient #medical #patientcare #hospitals #dialyse #nephrology #dialysis #endstagekidneydisease #chronickidneydisease #kidneydialysis #femaleempowerment #peritonealdialysis #peripal #perisafe

2 views0 comments

Recent Posts

See All

We are hiring!

We are looking to strengthen our sales team for our new product PeriSafe that enables more dialysis patients to be treated at home. We are looking for a strong, motivated candidate who has sales exper

Folge uns

  • YouTube


Kontakt Informationen

Peripal AG

Limmatquai 112

8001 Zürich


Tel.: +41 44 221 95 40

© 2020 by Peripal AG